Albuterol HFA MDI in Pediatric Participants With Asthma
- Study Title
- Albuterol HFA MDI in Pediatric Participants With Asthma
- Teva Identifier
- IXR-302-25-105
- ClinicalTrials.gov Identifier
- NCT00577655
- Study Status
- Completed
- Trial Condition(s)
- Asthma
- Interventions
- Drug: Albuterol | Drug: Placebo | Drug: Proventilֲ® HFA
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child
- Age Range
- 4 Years to 11 Years
- Trial Duration
- 08/01/2007 - 07/01/2008
- Phase
- Phase 3
